Daye

United Kingdom
Newdigate, England, United Kingdom, SE16 4DG

Company profile

Daye company profile

Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause. The company was founded in 2017

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
SE16 4DG
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$17.1M
Last funding
Series A / $11.6M / 2022-10-26
Last equity funding
Series A / $11.6M
Investors
13
Lead investors
3
Founders
1
Articles
27

Founders and investors

Founders

Valentina Milanova

Lead investors

Google for StartupsKhosla VenturesSalica

Investors

Google for StartupsIndex VenturesKhosla VenturesKindred CapitalSalica